Xcout IntelSign inSubscribe

c-LEcta

BiotechnologyLeipzig, Germany

Headquartered in Leipzig, Germany, c-LEcta GmbH is a global biotechnology company specializing in enzyme engineering and bioprocess development for industrial applications, operating as part of Kerry Biotechnology.

Subscribe to see c-LEcta’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

c-LEcta at a glance

c-LEcta is a biotechnology company headquartered in Leipzig, Germany, founded in 2004. Xcout tracks 8 named people at c-LEcta, including Dr. Marc Struhalla (CEO and Founder).

As of 16 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
Leipzig, Germany
Founded
2004

c-LEcta leadership

  • Dr. Marc StruhallaCEO and Founder
  • Carsten FietzSenior Vice President Finance & Administration
  • Dr. Andreas ButheVice President Business Development
  • Dr. Andreas VogelVice President R&D Enzyme Development
  • Dr. Arnd KnollVice President Production
  • Dr. Mathias BellVice President Legal, IP, Licensing

2 more named people on record for c-LEcta, with roles, board committees and tenure — see the full roster →

c-LEcta competitors

A few of c-LEcta's closest competitors — see the full list of competitors and alternatives →

Codexis, Inc.CDXS · BiotechRedwood City, CA, United States
63% matchPublic

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.

Market cap$104.9M
Employees188
Codexis, Inc. competitors & alternatives →

Get c-LEcta's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about c-LEcta? Suggest a correction · Work at c-LEcta? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

c-LEcta on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

c-LEcta — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on c-LEcta in Xcout Intel

  • 8 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →